Health
Fortune or foresight? AstraZeneca and Oxford’s stories clash on COVID-19 vaccine – The Japan Times
The two partners have given conflicting accounts of how they came upon the most effective dosing pattern for their COVID-19 vaccine.
LONDON – AstraZeneca and Oxford University have given conflicting accounts of how they came upon the most effective dosing pattern for their COVID-19 vaccine, a rare instance of public dissension between major institutions collaborating on a pivotal project.
The discrepancy centers on the regimen administered to a smaller group of volunteers in the late-stage trials, of half a dose followed by a full dose. This diverged from the original plan of two full doses, given to the majority of participants.
…
-
Noosa News12 hours agoMan dies in Brisbane crash, women and girl rushed to hospital
-
General21 hours agoProductivity summit ends day two with progress on rules changes to boost housing supply
-
General22 hours agoSharp rise in airfares push UK inflation higher in July
-
Business17 hours agoAre BHP shares are buy after its results?